Mahmoud Aziz
Chairman presso GENIX PHARMACEUTICALS CORPORATION
Patrimonio netto: 192 590 $ in data 29/02/2024
Profilo
Founder of Asia Pacific CEO Association of Canada, Canagen Pharmaceuticals, Inc. and Oceanix Biotechnology Corp., Mahmoud S.
Aziz is an entrepreneur and businessperson who has been the head of 7 different companies and occupies the position of Chairman & President of Genix Pharmaceuticals Corp., Chairman & Chief Executive Officer at The Fazio Group of Cos.
Ltd., Chairman & President for Oceanix Biotechnology Corp., Chairman & President of Canagen Pharmaceuticals, Inc. and President & Chief Executive Officer at SinoPharm, Inc. Mr. Aziz is also Chairman at Asia Pacific CEO Association of Canada.
Mr. Aziz previously held the position of President & Chief Executive Officer of Sino Pharmaceuticals Corp.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
11/04/2023 | 6 419 671 ( 10.84% ) | 192 590 $ | 29/02/2024 |
Posizioni attive di Mahmoud Aziz
Società | Posizione | Inizio |
---|---|---|
GENIX PHARMACEUTICALS CORPORATION | Chairman | 18/05/2023 |
The Fazio Group of Cos. Ltd. | Chief Executive Officer | 01/01/1983 |
SinoPharm, Inc.
SinoPharm, Inc. Pharmaceuticals: MajorHealth Technology SinoPharm, Inc. produces and develops generic pharmaceuticals. The company's products include medaxol, active pharmaceutical ingredient (API), and anti-cancer compound extracted from the Chinese Yew tree, and docetaxel. The company was established in 2001 and is headquartered in Richmond, Canada. | Chief Executive Officer | - |
Asia Pacific CEO Association of Canada
Asia Pacific CEO Association of Canada Miscellaneous Commercial ServicesCommercial Services Asia Pacific CEO Association of Canada operates as a association for politicians, industrialists and financial leaders. The company was founded by Mahmoud S. Aziz in 2007 and is headquartered in Richmond, Canada. | Founder | 05/08/2010 |
Oceanix Biotechnology Corp. | Founder | - |
Canagen Pharmaceuticals, Inc. | Founder | 01/01/2001 |
Precedenti posizioni note di Mahmoud Aziz
Società | Posizione | Fine |
---|---|---|
GRAND PEAK CAPITAL CORP. | Director/Board Member | 27/03/2008 |
XTACY THERAPEUTICS CORP. | Director/Board Member | - |
Sino Pharmaceuticals Corp.
Sino Pharmaceuticals Corp. Financial ConglomeratesFinance Sino Pharmaceuticals Corp. engages in the development, manufacture, and marketing of generic pharmaceuticals. The company was founded in 1997 and is headquartered in Richmond, Canada. | Chairman | 05/08/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
XTACY THERAPEUTICS CORP. | Finance |
GENIX PHARMACEUTICALS CORPORATION | Health Technology |
GRAND PEAK CAPITAL CORP. | Finance |
Aziende private | 6 |
---|---|
Sino Pharmaceuticals Corp.
Sino Pharmaceuticals Corp. Financial ConglomeratesFinance Sino Pharmaceuticals Corp. engages in the development, manufacture, and marketing of generic pharmaceuticals. The company was founded in 1997 and is headquartered in Richmond, Canada. | Finance |
SinoPharm, Inc.
SinoPharm, Inc. Pharmaceuticals: MajorHealth Technology SinoPharm, Inc. produces and develops generic pharmaceuticals. The company's products include medaxol, active pharmaceutical ingredient (API), and anti-cancer compound extracted from the Chinese Yew tree, and docetaxel. The company was established in 2001 and is headquartered in Richmond, Canada. | Health Technology |
The Fazio Group of Cos. Ltd. | |
Asia Pacific CEO Association of Canada
Asia Pacific CEO Association of Canada Miscellaneous Commercial ServicesCommercial Services Asia Pacific CEO Association of Canada operates as a association for politicians, industrialists and financial leaders. The company was founded by Mahmoud S. Aziz in 2007 and is headquartered in Richmond, Canada. | Commercial Services |
Oceanix Biotechnology Corp. | |
Canagen Pharmaceuticals, Inc. |